Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MRI Assessment of Leukemia Response to Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by OHSU Knight Cancer Institute
Sponsor:
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT01537159
First received: February 14, 2012
Last updated: March 21, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)